New treatment for cows in postpartum endometritis
In veterinary medicine, some effective complex drugs are currently known for the treatment of cows in postpartum endometritis. However, many of them have antibiotics in their composition, and this entails restrictions on the slaughter and use of milk during the treatment period. The purpose of the work is to study the therapeutic effectiveness of the new agent and the drug «Tilosinokar» in postpartum endometritis in a comparative aspect. The experimental preparation (in the following percentage of components: pharmaceutical oxidine - 15 %, povidone iodine - 1 %, alantoin - 5 %, aloe extract - 2.5 %, retinol palmitate (vitamin A) - 15 %, tocopherol acetate - 4 %, renin - 10 %, trypsin - 10 %, chymotrypsin - 10 %, propranolol - 5 %, glycerin - 2.5 % A control group of animals was treated with Tilosinokar. The preparations were administered at a dose of 100 ml per animal intrauterine once every 24 hours. A new highly effective drug for treating postpartum endometritis in cows has been developed, which has a disinfectant, regenerative, antihistamine effect, has no restrictions on the use of animal products, since it does not contain antibiotics, contains proteolytic enzymes and additives of biological origin. As a result of the studies, it was revealed that the effectiveness of the new agent in postpartum endometritis was higher compared to the use of the preparation "Tilosinokar" and contributed to the improvement of the overall and local condition of the animal and positively affected the hematological and biochemical blood indices.